Authorities make third party audits subject to a number of conditions: the drug manufacturer must for example ensure that auditors have the requisite professional expertise and independence. At the blue inspection body this is done centrally by a notified body, the Deutsche Akkreditierungsstelle (DAkkS). The quality of the content and the depth of the inspections are also checked by the DAkkS. Accreditation as an inspection body is thus an important quality criterion for those commissioning third party audits. It ensures that a GMP inspection is impartial and is performed to a high standard of quality, reliability and efficiency.
blue inspection body GmbH performs GMP audits for drug manufacturers and contract manufacturers on the basis of Part II of the EU GMP guideline. The first step is to establish what specific requirements the client wants his active pharmaceutical ingredient to meet.
The GMP auditor prepares a third party audit plan on this basis and suitable auditors are assigned. The actual inspection is performed on site at the premises of the API supplier in accordance with specified standards. In an internal review process, an assessment is made of the quality of the inspection itself, the GMP compliance found and the measures proposed by the supplier to eliminate any deficiencies identified. The client receives a full, certified audit report for final assessment.
We can act directly on behalf of the manufacturers of APIs: blue undertakes all aspects of GMP compliance monitoring and performs a third party audit on the initiative of the manufacturer. The manufacturer can then make reports on the audited active pharmaceutical ingredients available to his customers. Unlike GMP certificates from a particular country – which according to the GMP guideline are explicitly not recognized as GMP audit in the EU – thanks to accreditation, certified active pharmaceutical ingredient inspections by blue may be used internationally.
Suppliers of pharmaceutical excipients and active pharmaceutical ingredients also make use of the service of blue inspection body GmbH. Based upon the recognized audit reports of the accredited inspection body, an independent qualification and surveillance of the API manufacturers is achieved. Simultaneously these accredited audit reports represent a valuable extension of the necessary regulatory GMP documentation for drug manufacturers.